Search

Winners of the 2019 European PRRS Research Award

Winners of the 2019 European PRRS Research Award announced.

Health equity for underserved communities

Introducing initiatives that improve access to healthcare for underserved communities

AMR_Action_Fund

Boehringer Ingelheim joins AMR Action Fund to support antibiotic R&D

We invest in our people so they will stay and grow with us. We offer benefits such as rewards and development opportunities to help retain employees.

Cooperation with The Defeat-NCD Partnership

Together with The Defeat-NCD Partnership, Boehringer Ingelheim aims to address key access to healthcare issues related to non-communicable diseases.

“Rare diseases are quite common”

Rare diseases are individually rare but collectively affect millions of people worldwide. Yet, they remain under-researched and are often misdiagnosed.

Main Meal

You can browse through all of the filling main meal recipes from Taking Cancer on Through Flavour here.

Sore Mouth or Throat

Discover tips on how to take care of a sore mouth or throat from Taking Cancer On Through Flavour

Groundbeaking of vaccine production center in France

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

Positivity... just a paw away

Data released by Boehringer Ingelheim shows the 96% of dog owners and 91% of cat owners claim their pet has a positive impact on their daily lives.

Dirk Stenkamp

Dirk Stenkamp, Senior Vice President Research Site Germany, reflects on our culture of collaboration and passion for progress.

STOP Rabies: moving towards elimination

Rabies still kills thousands of people every year. However, rabies is 100 percent vaccine preventable. We contribute to eliminating the disease.

Financial health

We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.

Research-collaboration-Gubra-obesity-treatment

Boehringer Ingelheim and Gubra enter collaboration to identify and validate targets and innovative peptides for the treatment of obesity.

R&D - Transforming tomorrow

Manami Tsutsumi, Senior Associate Director in Research & Development describes what it's like working on the cutting edge of pharmaceutical development.

Over 100 billion birds vaccinated with VAXXITEK

Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.

Retinal health: All eyes on vision loss

Discover how we want to prevent vision loss caused by diabetic retinopathy and other retinal diseases

GPP Forum Article - Frida Dunger Johnsson, Executive Director, IFPA

Frida Dunger Johnsson, Executive Director of IFPA and panelist at the generalized pustular psoriasis (GPP) Forum, reflects on a momentous day

Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry

Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being

Animal Health

New exchange platform with Harbin Research Institute

Boehringer Ingelheim and Harbin Veterinary Research Institute set up ‘industry-academia-research’ exchange platform

Why is Diversity, Equity and Inclusion important to us?